Company Description

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States.

It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.

It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Precipio, Inc.

Country	United States
Industry	Diagnostics & Research
Sector	Healthcare
Employees	57
CEO	Ilan Danieli

Contact Details

Address: 4 Science Park, 3rd Floor New Haven, Connecticut 06511 United States
Phone	203 787 7888
Website	precipiodx.com

Stock Details

Ticker Symbol	PRPO
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001043961
CUSIP Number	74019L503
ISIN Number	US74019L6020
Employer ID	91-1789357
SIC Code	3826

Key Executives

Name	Position
Ilan Danieli	Founder, President, Chief Executive Officer and Director
Ahmed Zaki Sabet	Chief Operating Officer
Dr. Ayman A. Mohamed M.D.	Chief Technology Officer
Matthew Gage	Chief Financial Officer
Miri Chiko-Radomski	Chief Legal Counsel and People Officer

Latest SEC Filings

Date	Type	Title
Nov 12, 2024	144	Filing
Nov 7, 2024	8-K	Current Report
Nov 6, 2024	10-Q	Quarterly Report
Sep 6, 2024	8-K	Current Report
Aug 15, 2024	8-K	Current Report
Aug 13, 2024	10-Q	Quarterly Report
Aug 2, 2024	SC 13G	Statement of acquisition of beneficial ownership by individuals
Jun 25, 2024	8-K	Current Report
Jun 13, 2024	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 13, 2024	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material

View All SEC Filings